Company intelligence / Profile preview

Bedford Bridge

New York, New York, United Statesbedfordbridge.com ↗

Ownership: Private
Development stage: Other

Overview

Bedford Bridge was a New York-based venture capital firm founded in 2023 by David Berry and Eric Berry. The company invested in early-stage high-performance firms at the intersection of life sciences and technology—particularly those developing next-generation biomedical technologies such as gene therapy, diagnostics, AI-driven platforms, predictive analytics, and personalized medicine. As of April 2025 it is listed as inactive.

Therapeutic areas: NeurologyEndocrinologyOncologyOtherMultiple
Modalities: Gene therapyDiagnosticsAI-driven platformsPredictive analyticsPersonalized medicineDevicePlatform
Industry: Investors

Beyond the preview

Go deeper on Bedford Bridge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bedford Bridge.

Explore the full profile